Pre-specified secondary analysis of the Brazilian RESILIENT trial (221 patients, anterior large vessel occlusion stroke): thrombectomy vs medical treatment improved 90-day independence under age 70 (OR 4.08) but benefit was attenuated at ≥70 (OR 0.90; pinteraction 0.03).
Secondary analysisn = 221
Lima et al. Age Is an Effect Modifier of Thrombectomy Benefit in a Socioeconomically Vulnerable Stroke Population